Skip to main content
All lobbying filings

QUEST DIAGNOSTICS INCORPORATED

Lobbying for QUEST DIAGNOSTICS INCORPORATED

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $350,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 7
  • S 2355
    Patients Deserve Price Tags Act
  • HR 5582
    Patients Deserve Price Tags Act
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • S 2761
    RESULTS Act
  • HR 5269
    RESULTS Act
  • HR 5571
    Expanding Seniors’ Access to PFAS Testing Act
 Lobbying activity 3
Budget/Appropriations

Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

Health Issues

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation S. 2355 and H.R. 5582 - Patients Deserve Price Tags Act S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 Diagnostics and chronic disease prevention and treatment

Medicare/Medicaid

S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program Regulatory changes to Sec. 216 of the Protecting Access to Medicare Act of 2014 (PAMA)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem